Research Article
The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index
Figure 2
Levels of oxidized low-density lipoprotein (oxLDL) (a), oxLDL/LDLc (b), adiponectin (c), and leptin (d), for end-stage renal disease (ESRD) patients on chronic dialysis, according to the more prevalent comorbidities, diabetes mellitus (DM) and hypertension (HT). ; ; ; loss of significance after statistical adjustment for body mass index.
(a) |
(b) |
(c) |
(d) |